Examples of Drug Development Program in a sentence
WYETH-AYERST agrees that it will exert commercially reasonable drug development and marketing efforts that are consistent with those efforts undertaken in its own global pharmaceutical business to develop and market in the Field, throughout such areas of the Territory as it may reasonably determine, at its own expense, Antibacterial Products incorporating or derived from any Compounds which receive Antibacterial Product Designation (a "Drug Development Program").
Research Program shall refer only to the collaborative phase of the research effort and shall not refer to the selection of a Safety Assessment Candidate by Merck or to the Drug Development Program.
WYETH-AYERST will keep SIGA fully informed concerning the status of the Drug Development Program for each Licensed Product, it being understood that all such information is Confidential Information subject to all the terms and conditions of this Agreement, and particularly Article 4 hereof.
WYETH-AYERST will keep CHEMGENICS fully informed concerning the status of the Drug Development Program for each Antibacterial Product, it being understood that all such information is Confidential Information subject to all the terms and conditions of this Agreement, and particularly Article 5 hereof.
The progress and results of Merck's Drug Development Program, as well as such other information reasonably requested by Transcell relating to the progress, goals or performance of the Drug Development Program, will be reported to Transcell through semi-annual summary reports.
The Global Development Plan shall describe the activities to be carried out by Wyeth during each year of the Drug Development Program.
WYETH-AYERST or its Affiliates shall conduct a drug development program to develop Licensed Products in the field of human medicine, and in its sole discretion and through an Affiliate, in veterinary medicine, and henceforth market Licensed Products in the Field incorporated or derived from any Compounds discovered or identified as a result of the R & D Program, which reach Pre- Project Status and which are selected by WYETH-AYERST or its Affiliates for development (a "Drug Development Program").
Continues Strong Performance from Consumer Products Division with Reported Sales of $2.5 Million for Q2 2016-Company Initiates Preclinical Drug Development Program to Address $5.3 Billion Market Opportunity in Cessation of Smokeless Tobacco Las Vegas, Nevada, August 12, 2016 – CV Sciences, Inc.
The National Cancer Institute Division of Cancer Prevention has established a Cancer Preclinical Drug Development Program called PREVENT.
Under the Drug Development Program, ATL will develop and commercialize antisense drugs arising out of the Collaborative Research Program conducted hereunder as well as ISIS 107248, a Collaboration Compound discovered by ISIS.